Furthermore, we observed that BC patients in the ER+, PR+, and HER2+ subgroups exhibited longer DSS and OS (Supplementary Table 2 and Supplementary Figures 1 and 2 in the attachments). The gene discussed is ERBB2; the disease is breast cancer.